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Summary
What is already known?
 ► Standard procurement processes exist for EPR sys-
tems including numerous elements.
 ► The discriminatory utility of components is poorly 
described
 ► The process is resource heavy and costly and learn-
ing dissemination would be useful.
What does this paper add?
 ► During EPR procurement, use of raw objective func-
tional assessment provides poor discriminary value.
 ► Demonstrations and site visits represent important 
discriminatory elements.
 ► Evaluation processes should be modified the meet 
the specific needs of the organisation.
AbStrACt
background This study describes learning from 
procurement of a comprehensive electronic patient 
record (EPR/electronic health record (EHR)), system for a 
specialist clinical academic institution.
Method Retrospective review of procurement process in 
addition to evaluation of peer-reviewed literature in the 
field.
results Main lessons learned include the importance 
of detailed preparation of organisational requirements/
specifications and organisational ‘readiness’. Early staff 
involvement, resulting in ownership of the selected system 
by the organisation was a key achievement. The scoring 
process used required significant resource commitment 
but, despite being extensive in scope, provided relatively 
poor distinction between suppliers, despite significant 
variation in supplier self-scoring. Other elements, such 
as demonstrations and site visits, provided superior 
evaluation of functional abilities, and specification 
requirements should be regarded as threshold evaluation.
Conclusion While principles should be followed, the 
procurement process must be modified to meet the 
needs of the specific organisation, in terms of its clinical 
activities, digital maturity, existing infrastructure and 
budget.
IntroduCtIon
Great Ormond Street Hospital for Chil-
dren NHS Trust (GOSH/the Trust) and the 
associated UCL Institute of Child Health 
represent a partnership of a large, specialist 
Children’s Hospital in London with extensive 
research and academic activity. As a compo-
nent of a larger piece of work on an overar-
ching digital strategy, GOSH has undergone 
an Official Journal of the European Union 
(OJEU) procurement process, with competi-
tive dialogue. The procurement was managed 
under two ‘Lots’. The scope of Lot1 was an 
enterprise electronic patient/health record 
(EPR/EHR) system to replace many of the 
current clinical systems in place across the 
Trust. The scope of Lot2 was a dedicated 
secondary use data repository, and research 
and analytics platform (Digital research 
environment (DRE)), replacing numerous 
individual research databases.
At the outset of the process we intended 
to use learnings from published evidence, 
but while numerous peer-reviewed papers 
regarding healthcare implementation were 
available,1 there was a paucity of practically 
useful publications regarding details of the 
process and learnings from other centres 
regarding EPR systems. The use of clin-
ical scenario simulation and evaluation for 
usability has been described,2 as have the use 
of usability questionnaires,3 but no informa-
tion was available regarding practical lessons 
from other centres, such as which elements 
of the evaluation process were most discrimi-
natory and whether there were specific issues 
detected during the procurement process 
which would have been useful to have been 
aware of initially. Therefore, following our 
EPR procurement process, the aim was to 
present our experience, which we hope may 
be useful for other organisations undergoing 
similar procurement processes.
The objectives of the current study are to 
describe details of the procurement process 
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Figure 1 Schematic illustrating timescales and elements of the procurement process.
used, review existing published literature providing data 
in this area, present data regarding the methodology used 
and present the major lessons learned from the process, 
all of which may benefit other organisations considering 
a major EPR procurement process.
Methods: details of procurement process
In the United Kingdom National Health Service (NHS), 
there are existing detailed general guidelines and regu-
lations governing all procurements, and similar struc-
tures exist elsewhere, in order that the organisation can 
satisfy both its own governance arrangements and legal 
requirements. Each organisation will have its own agreed 
Standing Financial Instructions (SFIs) which detail the 
process to be followed for each procurement depending 
on the value of the procurement. In the case of GOSH 
this states that all contracts with a value of over £1 million 
require board approval.
To satisfy the legal requirements all procurements 
above £100,000 are tendered through OJEU guidelines 
(2015; https://www. ojeu. eu/ whatistheojeu. aspx), which 
govern the procedural and legal aspects (figure 1). 
There are methods implemented within the regulations 
to allow for the large-scale purchase of items such as 
hardware or more innovative partnerships for bespoke 
developments of new software. This can either be done 
through a previously OJEU tendered framework (http://
www. lpp. nhs. uk/ categories/ technology- consultancy/ 
clinical- and- digital- information- systems/) or through a 
separate OJEU procurement. The framework is an agree-
ment with a provider or number of providers following 
Public Contracts Regulations that enables buyers to place 
contracts by direct award or following a mini-competition 
without running full tendering exercises. Frameworks 
will carry their own terms and conditions which can be 
restrictive, however, the process reduces the cost and time 
of procurement.
When GOSH evaluated its option, some of the newer 
frameworks were not available, or did not contain a 
comprehensive list of suppliers, and GOSH opted for 
a new procurement. Procurement of an EPR, from the 
production of the detailed specification, legal limitations 
and scoring criteria generally require specialist expertise 
not available in an NHS Trust, therefore services of an 
experienced EPR procurement supplier were sought. The 
use of such specialist procurement advisors adds value, 
since they will have been involved in recent procurements 
and know the marketplace and the potential suppliers, 
in addition to being able to provide content on which to 
base the procurement. This aims of reducing time and 
cost, allows the organisation to customise the content 
and focus their specialised needs (as a tertiary children’s 
hospital in this case). The advisors led the Trust through 
the procurement process, producing documentation, 
crafting supplier communication and participating in 
dialogue sessions. While LOT1 and LOT2 procurements 
followed a similar process, we focus here on the LOT1 
EPR system procurement only.
Following procurement launch, prequalifying ques-
tionnaires were received from nine suppliers from which 
three fulfilled the essential criteria and were invited to 
submit initial tenders. The trust had internally devel-
oped an extensive list of specifications required from 
the EPR system (output-based specification (OBS)). 
A pre-determined minimum compliance level of 70% 
was required for supplier invitation to the next round 
(dialogue) in order to optimise supplier and Trust time. 
There were >5000 rows within the OBS, of which>3400 
items were individually scored, each on a scale of 0–6: 0 
representing no evidence of compliance, 4 representing 
adequate compliance and 6 representing compliance 
with additional beneficial features. For each item score, 
the supplier was requested to self-score and the Trust 
generated a moderated score based on discussion of the 
information provided (figure 1).
The authors of the current manuscript were involved 
in the procurement process at all stages, from conception 
and requirement gathering, through specification selec-
tion, evaluation, dialogue and final selection. In addition, 
the authors were members of an EPR programme board, 
which reviewed and discussed the process and outcomes.
reSultS: SCorIng
There were two suppliers that reached the final stage 
of dialogue. For these suppliers, around 90% of their 
responses demonstrated adequate compliance with 
the OBS requirements and had similar supplier self-
scores and moderated scores. Therefore, around 3000 
elements of the OBS provided assurance regarding 
EPR product functionality, but were not discriminatory 
between suppliers. Overall, the moderated scores were 
greater than the supplier self-scores in around 0.5% of 
cases and lower in 7%–12% of cases. There was a signif-
icant difference in supplier-moderated discordance and 
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‘overscoring’ between suppliers (242/3432 vs 407/3432 
respectively; Z=−7.0, P<0.0001). There were 80 (approx-
imately 2%) specifications in which the moderated and 
self-scores differed by at least two marks, these there-
fore representing areas requiring extensive clarification 
during dialogue and being potentially discriminatory. 
These areas specifically related to: care pathways, patient 
flow, operational surveillance, consent, pharmacy and 
laboratory medicine.
The OBS scores were based on documentation 
provided by the suppliers, with subsequent clarification 
during dialogue. The total cost of ownership also formed 
a significant part of the overall final evaluation score, in 
addition to OBS scores, functionality, usability, such that 
an overall final score was applied to suppliers. A prede-
termined cut-off was used to ensure that any successful 
supplier could fulfil the essential requirements of the 
organisation, and for suppliers meeting that score, they 
were ranked based on the final score taking account of all 
aspects as above. However, the organisation did not elim-
inate any supplier purely on cost, but rather total cost of 
ownership vs potential benefits was evaluated.
Site visits were performed by a mixed group of tech-
nical, operational and clinical staff of multiple hospitals 
using the systems. The suppliers were encouraged to 
identify sites (including international sites) which best 
demonstrated the potential of their systems applied to a 
hospital broadly similar to the organisation. These were 
not scored in the same way as the OBS requirements, 
but rather, the findings were translated into a negative 
risk score which was then attributed to the other scored 
criteria. Thus the site visits evaluated whether the systems 
were being used in practice to the extent that the OBS 
score represented and if not, how much risk this consti-
tuted to the overall benefits case. If the functionality stated 
in the OBS could not be demonstrated in clinical prac-
tice, the procurement process took the view that although 
the systems could be shown to theoretically perform the 
function to their full potential then other factors such as 
human behaviours (and in particular, ‘usability’) were a 
factor. Therefore, site visits were used to provide a risk 
score regarding the likely delivery of specific elements 
based on both how the systems were being used at other 
site organisations in addition to the planned workflows 
at GOSH. Dialogue sessions were undertaken to clarify 
specific elements of functionality or questions regarding 
system modules which had been highlighted suring the 
objective scoring. The dialogue sessions themselves were 
not individually scored, rather the process of clarification 
was used to allow modification of the scoring elements as 
appropriate.
reSultS: leSSonS leArned
Throughout the process the senior EPR team undertook 
numerous meetings to discuss the ongoing procurement 
through the EPR board, including discussion of supplier 
scores, functionality and feedback, in order to make the 
procurement decision. Following the process, the team 
also discussed and reflected on ‘lessons learned’ from 
the procurement. These ‘lessons’ were not formally 
scored in terms of importance but were collated and are 
presented below, presented by general theme but not in 
specific ‘ranked order’ of importance. However, we have 
attempted to present what we feel are the priority areas 
initially within the appropriate sections. The elements 
include both positive and negative aspects, which were 
highlighted as part of the organisational reflection on the 
EPR procurement. Where appropriate, mitigation strate-
gies are also described.
overall organisation of process
Development of a stakeholder map of key staff groups 
prior to commencement of the procurement process, 
along with securing protected time for these staff to be 
actively involved throughout resulted in excellent levels 
of clinical engagement with the process (>200 clinical and 
operational staff from across all areas of the hospital were 
involved to avoid EPR being envisaged as an ‘IT’ project). 
Poor staff inclusion has been previously reported as a 
factor associated with unsuccessful implementations.1
Clear articulation of the overall vision by the executive 
team, in terms of high-level outcomes describing new 
ways of working supported by the EPR system and associ-
ated benefits, resulted in early recognition by staff of the 
scale and importance of the project. At the procurement 
stage it is important that the entire organisation under-
stands the expected outcomes and process.
Involvement of the procurement team in wider market 
testing, including liaising with staff at similar organisa-
tions who have completed a similar process resulted in 
awareness of likely practical areas of possible difficulty or 
delay. These ‘shop floor’ difficulties are hard to predict 
other than through experience.
Procurement process and scoring
The initial procurement requirements and vision should 
be modified based on findings from scoping and other 
organisations such that development of functional and 
non-functional requirements is focused on support for 
key outcomes for the specific organisation.
Time should be spent determining requirements based 
on the specific clinical activity of the organisation. For 
example, workshops and focus groups were completed to 
determine the OBS requirements across all areas.
Early identification of likely system biases allows 
their management and mitigation. For example, some 
members of the procurement team may have had expe-
rience of the specific systems being evaluated (either 
positive or negative). While previous experience can be 
useful, there are many reasons why a system may appear 
to work better or worse at different sites (such as under-
lying infrastructure, workflows, scope of procurement 
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While detailed specifications provided assurance 
regarding fitness for purpose of the system, the data 
presented here demonstrate that most scores did not 
distinguish between potential suppliers, while repre-
senting a significant investment of time and resource 
from Trust and suppliers. In retrospect we suspect that 
a significantly reduced process, perhaps requiring check-
boxes for compliance for many areas, may have resulted 
in a similar outcome with less resource.
Since all suppliers of major EPR systems can provide 
high-level similar functionality, the OBS may not clearly 
separate suppliers, rather objectively determining a 
‘threshold’ level of functionality.
A reduced OBS scoring process could be related to 
provision of detailed example workflow objectives for 
system elements. This would represent a reduced burden 
on both organisation and suppliers, but with a focus on 
specific issues which are likely to be discriminatory.
Despite most scores being consistent, there was signifi-
cant variation in supplier self-scoring against OBS require-
ments, hence organisational scoring is also required to 
reduce bias from supplier ‘overscoring’.
Despite using a scoring approach in which a score of 
6 could be used to allow demonstration of exceptional 
system capability, overall aggregate scores poorly demon-
strated such areas due to most scores meeting require-
ments, reducing the impact of this approach.
While being associated with shortcomings, the OBS 
exercise allowed the selection team to foster deep under-
standing of what was needed from such an enterprise level 
platform and helped create an active multiprofessional 
team from clinical, operational and support backgrounds.
Additional evaluation elements
The dialogue and demonstration process provided 
important clarification, since there may be several ways 
to fulfil a given specification. In written terms the spec-
ification may appear non-discriminatory but practical 
scored demonstrations allows clarification regarding 
whether the approach would fit within the organisation 
and workflows.
Increased focus on elements in addition to specifica-
tion scoring, such as scripted demonstrations, usability 
assessments and site visits, provide highly valuable insights 
regarding how systems may fit into specific organisa-
tional teams and cultures, and could provide enhanced 
discrimination.
Practical site visits were of major importance for eval-
uating the real-world applicability of systems and risk 
scoring from the site visits was invaluable in providing real 
world value, and thus an indication ultimately of the total 
cost of ownership (TCO). There are several ways that a 
‘specification’ may be met, which may markedly vary in 
compatibility with specific organisational activity. To this 
end, choice of sites to visit is of importance and should 
include ‘real world’ examples of similar organisations, in 
terms of size and type of clinical services, in addition to 
supplier nominated sites.
Procedural elements
Supplier demonstrations should be scripted based on 
real hospital workflows/patient scenarios, to provide eval-
uators a true view how a system may be used in practice. 
During such, suppliers should not be allowed to avoid 
demonstrating areas of the system that they may feel are 
weak. Highly polished demonstrations of pre-planned 
elements may not reflect future clinical usage.
Usability sessions as part of the scored demonstration 
element provides further insight into the practicalities of 
Trust staff using the system that has been demonstrated: 
this also provides an indication of ease of adoption. As 
many ‘user types’ as possible should evaluate the system, 
not only frontline clinical staff.
The use of procurement advisors was valuable in terms 
of providing insight into the marketplace, suppliers 
and provide balance to the process, but advisors should 
concentrate on technical procurement advice and should 
not become involved in system demonstrations, site visits 
or other ‘softer’ elements of the process since they may 
have unconscious bias from previous procurements and 
may not understand specifics of the organisation.
Technical and infrastructure requirements must be 
fully evaluated and included in the procurement process 
internally, even if not part of EPR supplier procurement 
itself. Evaluation of trust IT infrastructure enables early 
awareness of the ‘readiness’ of the organisation for EPR 
implementation. For example, it was recognised early 
that the networking/wireless capabilities of the organisa-
tion were inadequate for future demand and the upgrade 
process was planned well ahead of EPR implementation.
Engaging other stakeholders into the evaluation 
process (particularly patient representatives) provided 
an additional perspective on systems and is important for 
including functionality such as a patient portal. We found 
that patient/family involvement in the entire process 
ensures focus remains on a usable system that will deliver 
benefits to patients.
dISCuSSIon
The findings of this study describe a UK procurement 
process for a comprehensive clinical EPR system for a 
specialist clinical academic institution. The main lessons 
learned, based on reflection of the entire process by the 
senior EPR team, include the importance of detailed 
preparation of organisational requirements/specifica-
tions and organisational ‘readiness’. Early staff involve-
ment was beneficial, resulting in ownership of the 
selected system by the organisation as a key achievement. 
In contrast, the scoring process used required significant 
resource commitment by both suppliers and organisa-
tion but despite being extensive in scope, provided rela-
tively poor distinction between suppliers in itself, despite 
significant variation in supplier self-scoring: whether 
such ‘overscoring’ was intentional or incidental cannot 
be determined from this data. Other aspects of the 
process, such as demonstrations and site visits, provided 
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subjectively superior evaluation of functional abilities, 
and we suggest that the specification requirements should 
best be regarded as a threshold- setting process.
The inclusion of ‘real-world’ usability testing was a 
significant and useful component of evaluating systems. 
This is similar to findings from a previous study in which 
novice users of a system were asked to identify potential 
usability issues for early recommendations for correc-
tion. These users had greater satisfaction with the system 
compared with experienced users of another system, who 
did not undergo usability testing prior to implementation, 
and who subsequently had relatively high levels of dissat-
isfaction.4 In the present study, usability testing provided 
both important immediate feedback from many types of 
potential system users but also the widespread inclusion 
of staff groups encouraged involvement and ownership 
with the process, generating enthusiasm from such staff 
and their peers, regarding the anticipated system once 
implemented.
The Trust felt that the process and opportunity to nego-
tiate with the successful bidder under the Public Contracts 
Regulations 2015 Competitive Dialogue process would 
help to establish a solid partnership with the chosen 
supplier and ensure that development and implemen-
tation plans were developed jointly. This allowed a wide 
selection of suppliers to participate while facilitating early 
exclusion of inappropriate suppliers-based criteria such as 
financial status and technical inability to deliver require-
ments. In choosing the ‘dialogue method’, throughout the 
course of procurement, the requirements and implemen-
tation plan could be developed and refined with suppliers 
to ensure the solution was optimal for the Trust. However, 
such a process is time consuming, likely to take up to 12 
months to complete even with a well-organised dialogue 
period and the necessary resources allocated from the 
Trust. For some organisations, alternative processes may 
be more appropriate. For example, in the UK a ‘frame-
work’ route might be equally successful, especially with 
limited scope of requirements, since it is likely to cost 
less. While in general, framework agreements are a useful 
and effective approach for smaller purchasing decisions, 
these are usually not indicated for major procurements 
such as comprehensive EPR systems.5 The reasons for this 
include the fact that not all EPR providers may be avail-
able through the framework process, thus reducing the 
scope of potential vendors, and frameworks are based on 
preselected criteria, which may be beneficial in specific 
circumstances but when considering enterprise EPR solu-
tions, the scale and complexity of requirements may be 
incompatible with a framework approach. The previous 
UK National Programme for IT could be argued as an 
example of how the framework-type approach may not 
work well for complex programmes across varied NHS 
organisations.
In addition, it is important to emphasise that the aim 
of the process is to procure the best affordable system, 
and therefore the procurement process required, and 
specifications are constrained by the overall budget, 
including long-term total cost of ownership (TCO). EPR 
systems require significant ongoing workflow optimisa-
tion, upgrade management and other maintenance and 
it is important that TCO, including Trust resource input, 
is evaluated rather than simply ‘purchase cost’.
Compared with evaluations of implemented EPR 
systems, there are a paucity of published data examining 
EPR procurements and implementations, although the 
importance of well-defined strategies for planning and 
procurement are established.6 The concept of important 
preimplementation phases for EPR projects, including 
scoping, methods of assessment, strategic planning and 
method of choosing a system have been well described,7 
but there is little evidence supporting specific scoring and 
comparative system evaluation aspects, supporting our 
approach of using established core principles with super-
imposed specific evaluation methods. Recently, a detailed 
framework for planning EPR usability evaluation has been 
described based on objectives, attributes and measures, 
which may provide the structure for determining usability 
elements in future selections.8
Recently, across the NNHS, procurement has been 
identified as a potential area for efficiency savings and 
a review of more than 70 procurement studies reported 
that efficient procurement processes were associated 
with good relationships with suppliers, development of 
skills to make good decisions and best use of technology. 
However, published evidence to support specific procure-
ment approaches was either absent or poor quality, most 
being simple descriptive studies. It is therefore recognised 
that there is a need for research to assess optimal procure-
ment approaches in many settings, with evaluation of 
practices, such as the present study.9 An NIHR study 
reviewed peer-reviewed published literature regarding 
buying behaviour, contracting economics, organisational 
relationships and supply chain management in the NHS 
and concluded that this was a complex process with a wide 
variety of practices and with significant impact of political 
aspects to most major procurement decisions.10 Finally, in 
addition to immediate requirements, the EPR platform 
should support future developments. Prediction of tech-
nological futures is fraught with difficulty, however, it is 
likely that cross-platform approaches, such as SMART on 
FHIR-compatibility, will be important for future integra-
tion of apps into the EPR system, and this approach has 
successfully been described.11
In conclusion, we have presented lessons learned from 
a comprehensive EPR system procurement for a specialist 
UK hospital, in addition to evaluation of the existing 
peer-reviewed literature in the field, which should be 
beneficial to other organisations undertaking similar 
projects. The main finding is that an EPR procurement 
process is a complex, pan-organisation issue, and evalu-
ation should be optimised for the specific organisation, 
including multiple assessment methods from core spec-
ification through usability. Given the increasing imple-
mentation of comprehensive EPR systems there is paucity 
of published evidence regarding optimal scoring and 
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evaluation methodologies and outcomes, and further 
work should focus on these areas. In addition, it would 
be useful to have publicly available, core documents 
regarding elements which are likely to be common 
across organisations, to be included in elements of the 
procurement and evaluation process, such as site visit and 
demonstration checklists and templates, which could be 
developed by the community.
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